The Inflation Reduction Act will ultimately raise drug costs and reduce future cures.
FDA Hurts Patients By Authorizing Florida’s Drug Importation Program
On January 5, 2024, the U.S. FDA authorized Florida’s drug importation program.
Misguided Use of March-In Rights Will Harm Patients
The use of march-in rights to steal intellectual property will neither lower costs nor create more access to healthcare.
Biden Price Controls Kill Innovation and Patients
IRA drug price controls will devastate future drug development, resulting in more lives lost.
Congress Should not Double Down on Devastating Drug Price Controls
House Democrats’ new bill on price controls will devastate future drug development and raise costs.
Biden’s Budget and the SMART Prices Act Will Devastate Drug Development
Pharmaceutical price controls in President Biden’s budget and the SMART Choices Act will devastate drug development.
Patients Pay the Ultimate Price for Price Controls
Price controls on pharmaceuticals distort the medical marketplace and will not lower drug prices.
New Study Confirms 340B Program is Exploited
A new study, “340B and Health Equity: A Missed Opportunity in Medically Underserved Areas,” shows the program is misused.
All Nations Must Respect and Protect Intellectual Property Rights
World Intellectual Property (IP) Day is a good time to remind all countries of the need to protect and respect IP rights.
CAGW Joins Coalition To Oppose Price Controls
CAGW joins 75 national and state-based organizations expressing their opposition to pharmaceutical price controls under the Most Favored Nations policy.